A review of new science, in plain language

eLife  ·  9 October 2026  ·  From issue 49

A membrane-disruptive action of VBIT-4 challenges its role as a widely used VDAC1 oligomerization inhibitor

A common lab drug damages cell membranes instead of blocking the protein clumping it was believed to stop.

Varun Ravishankar, Luís Borges-Araújo et al.

Integrity screen: passed (3 checks) Checked 12 October 2026. Read the source

The plain-language reading of this paper is in the full issue, for subscribers.

Read the full issue

Get it free, every two days

Five papers free every issue, about 15 emails a month. No spam. Leave in one click.

Also in issue 49 15 papers
More from eLife